About Us
Contact Us
Regulatory
Community
Site Map
Links
Stock Price
Glossary
Investor Relations
Media Gateway
Businesses
Governance
Uranium 101
Careers
Company Profile Why Invest? Events Calendar Management Views Financial Reporting Shareholder Information
Q3
Q2
Down Arrow
Q1
Contact IR
 
TSX:  $15.46 (-1.76)
NYSE:  $11.81 (-1.80)
  15 minute delay
Uranium Price
Print Page
Print Page

Cash Statement

Consolidated Statements of Cash Flows
(Unaudited)
($Cdn Thousands)

Three Months Ended Six Months Ended  
Jun 30/08   Jun 30/07   Jun 30/08   Jun 30/07  
  
Operating activities  
Net earnings $150,349  $204,877  $283,729  $263,381   
  Items not requiring (providing) cash:  
  Depreciation, depletion and reclamation 53,594  75,880  113,982  122,526   
  Provision for future taxes [note 11] (55,655) (15,496) (65,709) (66,546)  
  Deferred gains (14,901) (21,030) (79,347) (23,748)  
  Unrealized losses (gains) on derivatives (11,049) (12,164) 18,405  (13,804)  
  Stock-based compensation [note 13] (3,957) 2,355  (339) 9,400   
  Loss (gain) on sale of assets 31  -   (3,077) (4,893)  
  Equity in loss of associated companies 1,841  2,193  3,804  3,092   
  Restructuring of gold business [note 16] 1,800  -   6,600  -    
  Minority interest 7,105  10,420  18,482  15,196   
  Other operating items [note 15] (15,982) (91,699) (37,640) (10,506)  
Cash provided by operations 113,176  155,336  258,890  294,098   
  
Investing activities  
  Additions to property, plant and equipment (127,500) (115,822) (240,199) (228,142)  
  Increase in long-term receivables, investments and other (138,585) (10,800) (157,360) (10,463)  
  Proceeds on sale of property, plant and equipment (35) -   3,073  4,892   
Cash used in investing (266,120) (126,622) (394,486) (233,713)  
  
Financing activities  
  Decrease in debt (2,212) (4,851) (4,329) (3,871)  
  Increase in debt 41,391  -   38,471  6,320   
  Short-term financing 123,726  10,949  123,726  10,949   
  Issue of shares 422  6,559  701  21,951   
  Dividends (20,666) (17,671) (37,886) (31,763)  
Cash provided by (used in) financing 142,661  (5,014) 120,683  3,586   
  
  Decrease in cash during the period (10,283) 23,700  (14,913) 63,971   
  Exchange rate changes on foreign currency cash balances (1,076) (26,922) 3,864  (29,053)  
  Cash and cash equivalents at beginning of period 132,242  372,229  131,932  334,089   
Cash and cash equivalents at end of period $120,883  $369,007  $120,883  $369,007   
  
Cash and cash equivalents comprised of:  
  Cash $67,396  $96,957   
  Short-term investments 53,487  272,050   
  $120,883  $369,007   
  
Supplemental cash flow disclosure  
  Interest paid $10,714  $11,274  $22,883  $23,854   
  Income taxes paid $19,470  $31,973  $101,260  $108,302